statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	461
SG - Singapore	189
IT - Italia	160
CN - Cina	100
VN - Vietnam	85
BR - Brasile	38
HK - Hong Kong	36
BD - Bangladesh	34
DE - Germania	29
NL - Olanda	27
FR - Francia	23
ZA - Sudafrica	19
AT - Austria	17
RU - Federazione Russa	15
IN - India	13
GB - Regno Unito	12
PL - Polonia	12
FI - Finlandia	8
JP - Giappone	8
CH - Svizzera	7
IE - Irlanda	6
MX - Messico	6
AR - Argentina	5
CA - Canada	5
CO - Colombia	5
KR - Corea	5
SE - Svezia	5
PH - Filippine	4
PK - Pakistan	4
TN - Tunisia	4
TR - Turchia	4
ES - Italia	3
HU - Ungheria	3
ID - Indonesia	3
IQ - Iraq	3
CI - Costa d'Avorio	2
CL - Cile	2
CR - Costa Rica	2
CZ - Repubblica Ceca	2
GE - Georgia	2
JO - Giordania	2
LT - Lituania	2
MA - Marocco	2
MY - Malesia	2
SA - Arabia Saudita	2
TW - Taiwan	2
UZ - Uzbekistan	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AZ - Azerbaigian	1
BG - Bulgaria	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
EG - Egitto	1
IL - Israele	1
IR - Iran	1
KE - Kenya	1
LV - Lettonia	1
NI - Nicaragua	1
PA - Panama	1
PE - Perù	1
PY - Paraguay	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TT - Trinidad e Tobago	1
Totale	1.403

Nome	#
Allergenicity of tropomyosin variants identified in the edible insect Hermetia illucens (black soldier fly)	260
Combined effect of temperature and pH on the structure and IgE-reactivity of Arginine Kinase from the edible insect Hermetia illucens	223
Molecular characterization of the allergenic Arginine Kinase from the edible insect Hermetia illucens (black soldier fly)	182
The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs	115
Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate	104
Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment	98
Lipid transfer protein syndrome: How to save a life through careful education	91
Causes of Non-Adherence to Allergen-Specific Immunotherapy: A Foundation towards a Patient-Personalized Approach	88
Safety and adverse reactions in subcutaneous allergen immunotherapy: a review	86
Factors and co-factors influencing clinical manifestations in nsLTPs allergy: between the good and the bad	82
The risk of anaphylaxis on holidays	78
Indoor air pollution and atopic diseases: a comprehensive framework	18
Totale	1.425

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	14	0	0	1	2	2	3	0	0	5	0	0	1
2023/2024	115	0	3	4	4	23	8	22	9	14	12	3	13
2024/2025	399	18	8	32	18	33	41	16	24	56	38	37	78
2025/2026	897	81	76	116	106	110	59	70	33	78	81	48	39
Totale													1.425